Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data

Published:2012-06-30 Issue:1 Volume:24 Page:293-299
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

McClung M. R.,Zanchetta J. R.,Racewicz A.,Roux C.,Benhamou C.-L.,Man Z.,Eusebio R. A.,Beary J. F.,Burgio D. E.,Matzkin E.,Boonen S.,Delmas P.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://www.springerlink.com/index/pdf/10.1007/s00198-012-2056-0

Reference10 articles.

1. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282:1344–1352

2. Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11:83–91

3. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344:333–340

4. Brown JP, Kendler DL, McClung MR, Emkey RD, Adachi JD, Bolognese MA et al (2002) The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Calcif Tissue Int 71:103–111

5. Delmas PD, Benhamou CL, Man Z, Tlustochowicz W, Matzkin E, Eusebio R et al (2008) Monthly dosing of 75-mg risedronate on 2 consecutive days a month: efficacy and safety results. Osteoporos Int 19:1039–1045

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to reduce the onset of sleeve gastrectomy associated bone loss (STRONG BONES): Trial design and methods;Contemporary Clinical Trials Communications;2023-08

2. Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial;Hepatology International;2022-06-29

3. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women;Cochrane Database of Systematic Reviews;2022-05-03

4. Biochemical markers of bone turnover in osteoporosis;Marcus and Feldman's Osteoporosis;2021

5. Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study;Korean Journal of Family Medicine;2020-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3